Paul Hartmann AG (FRA:PHH2)

Market Cap	895.04M
Revenue (ttm)	2.43B
Net Income (ttm)	108.45M
Shares Out	3.55M
EPS (ttm)	30.53
PE Ratio	8.25
Forward PE	n/a
Dividend	8.00 (3.21%)
Ex-Dividend Date	May 2, 2025

Volume	15
Average Volume	15
Open	248.00
Previous Close	249.00
Day's Range	248.00 - 248.00
52-Week Range	183.00 - 258.00
Beta	0.56
RSI	51.40
Earnings Date	May 13, 2025

About Paul Hartmann AG

Paul Hartmann AG manufactures and sells medical and care products in Germany, rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Incontinence Management, Wound Care, and Infection Management. It offers body-absorbent products and traditional and modern wound dressings. In addition, the company produce single-use products and solutions for infection; hand, surface, and instrument disinfection; and cleaning, skin care, and skin antisepsis. Further, it offers Link, a pla...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1818
• Employees: 10,079
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PHH2

Financial Performance

In 2024, Paul Hartmann AG's revenue was 2.43 billion, an increase of 2.46% compared to the previous year's 2.37 billion. Earnings were 108.45 million, an increase of 281.58%.